Board of Director

Board of Director

Procedures for Election of Directors

The election of all directors follows the candidate nomination system in accordance with the Procedures for Election of Directors. Matters related to the professional qualifications, shareholding, determination of independence, nomination and election methods, and other requirements for independent directors shall all be handled in accordance with the relevant regulations of the securities regulatory authority.

All independent directors were elected in accordance with the aforementioned regulations. This process included submission to the board of directors for discussion and approval, the submission of relevant supporting documents to the company during the announced nomination period, and presenting the roster of director candidates at the shareholders’ meeting for election.

Pan-Chyr Yang

Chairman

Director , Representing
Oneness Biotech Co., Ltd.

Member of

Sustainable Development

and Nominating Committee

Current Positions

  • Academician, Academia Sinica
  • Professor of Internal Medicine, National Taiwan University College of Medicine
  • Vice President, Institute for Biotechnology and Medicine Industry (IBMI)

Past Positions

  • President, National Taiwan University
  • Dean, National Taiwan University College of Medicine

Selected Education

  • PhD, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine

Tsu-Der Lee Vice Chairman

Director , Representing

Oneness Biotech Co., Ltd.

Member of

Sustainable Development

and Nominating Committee

Current Positions

  • Director of Taipei Medical University
  • Independent Director of China General Plastics Corp.
  • Director of Diamond Capital Inc.
  • Director of Sun Biofund Inc.
  • Independent Director of Machvion Inc.
  • Deputy Chairperson of the investment committee of Diamond Biofund Inc.

Past Positions

  • Chairman of Taipei Medical University

Selected Education

  • D.D.S., School of Dentistry, Taipei Medical University

Che-An Chou

Director

Current Positions

  • Head of Biomedical Investment, Ultimate Epoch Ltd.

Past Positions

  • Consultant of EY-Parthenon Biomedical
  • Strategy Manager of Roche Pharmaceutical’s Pipeline

Selected Education

  • PhD, Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University

Der-Tsai Lee

Independent Director

Convener of Audit Committee,

Remuneration Committee,

and Sustainable Development

and Nominating Committee

Current Positions

  • Distinguished Visiting Chair of Research Center for Information Technology Innovation, Academia Sinica

Past Positions

  • Senior Advisor of National Security Council
  • President of National Chung Hsing University
  • Distinguished Researcher of Institute of Information Science, Academia Sinica
  • Professor of Department of Electrical Engineering and Computer Science, Northwestern University

Selected Education

  • PhD. in computer science, University of Illinois at Urbana-Champaign

Fei-Peng Lee

Independent Director

Member of Audit Committee

and Remuneration Committee

Current Positions

  • Chairman, Taiwan Hospital Association
  • Chairman of the Medical Foundation for Pathology Development
  • Director, Taipei Medical University
  • Director, Foundation of Chinese Dietary Culture
  • Director, Formosa Cancer Foundation

Past Positions

  • Vice President, Taipei Medical University
  • Dean, Taipei Medical University-Shuang Ho Hospital, MOHW
  • Director, Joint Commission of Taiwan
  • Chairman, Taiwan Nongovernmental Hospitals and Clinics Association

Selected Education

  • MD, Taipei Medical University

Shu-Hui Chang

Independent Director

Member of Audit Committee

and Remuneration Committee

Past Positions

  • Assistant Director of the Securities Issuance Section, FSC
  • Director, Accounting and Auditing Supervision Division, Securities and Futures Bureau, FSC
  • Manager of Strategy Department, Taipei Exchange
  • Chief Auditor, Internal Audit Office, Taipei Exchange

Selected Education

  • Department of Business Administration, Ming Chuan University
  • Master’s Program in Dept. of Business Administration, NCCU

Li-Ching Chen

Independent Director

Member of Audit Committee,

Remuneration Committee,

and Sustainable Development

and Nominating Committee

Current Positions

  • Independent director, ACON OPTICS COMMUNICATIONS INC.

Past Positions

  • Senior Auditor, KPMG Taiwan
  • Assistant Manager, Listing Supervision Department, Taipei Exchange
  • Manager, Listing Examination Department, Taipei Exchange
  • Manager, Startup Incubation Department, Taipei Exchange

Selected Education

  • Master of Business Administration, National Taiwan University

Chi-Yu Hsiang

Independent Director

Member of Audit Committee,

Remuneration Committee,

and Sustainable Development

and Nominating Committee

Past Positions

  • Deputy Director of the Secretariat, Taiwan Stock Exchange
  • Deputy Director of the Surveillance Department, Taiwan Stock Exchange

Selected Education

  • Bachelor, College of Law, National Taiwan University

Shih-Tsung Chang

Independent Director

Member of Audit Committee

and Remuneration Committee

Current Positions

  • Managing Partner of Shen-Ta CPA Firm
  • Arbitrator of Chinese Arbitration Association, Taipei
  • Arbitrator of Chinese Construction Industry Arbitration Association

Past Positions

  • Director of Taiwan Cooperative Bank
  • Team 1 and Team 6 Specialist, Securities and Futures Bureau, Ministry of Finance
  • Tax clerk for the Enterprise Income Tax Division & Estate and Gift Tax Division, National Taxation Bureau of Taipei, Ministry of Finance
  • Employee of Taiwan Business Bank
  • Inspector, Bankruptcy Supervisor, Bankruptcy Administrator, Trademark and Patent Agent
  • Member of the Accounting Standards Committee, Accounting Research and Development Foundation
  • Lecturer, Department of Accounting, Tamkang University
  • Lecturer, Department and Graduate Institute of Information Management, Yu Da University of Science and Technology
  • Supervisor of Universal Venture Capital Investment Corporation

Selected Education

  • Master, Department of Accounting, Tamkang University
  • Master, Department of Law, Chinese Culture University
  • PhD, School of Law, China University of Political Science and Law

Diversity of the Board of Directors

Specific Management Objectives of the Diversity Policy

The selection conditions of the Company’s Directors are not limited to gender, age, ethnicity, and nationality, and the Company also focuses on gender equality for the composition.
The Company explicitly stipulates in its Corporate Governance Best Practice Principles that the composition of the Board of Directors shall take diversity into consideration. In addition to the principle that directors concurrently serving as company managers should not exceed one-third of the total number of Board seats, the Company has formulated appropriate diversity policies based on its operational characteristics, business model, and development needs. Furthermore, starting from 2024, the Board shall include no fewer than one director of each gender.

Status of Achievement of the Diversity Policy

Among the directors of the sixth Board term, five directors are aged 71 or above, two are aged between 61 and 70, one is aged between 51 and 60, and one is under the age of 40. Currently, none of the Board members concurrently serves as the Company manager. All Board members possess professional knowledge and skills relevant to the Company’s required industry or financial background.
Independent directors account for two-thirds of the total Board seats, and three seats are held by female directors. The Company has effectively implemented the diversity policies and objectives as set forth in its Corporate Governance Best Practice Principles.
To enhance corporate governance, the Board as a whole possesses capabilities including, but not limited to, operational judgment, accounting and financial analysis, business management, crisis management, industry knowledge, international market perspective, leadership, decision-making, and risk management knowledge and competencies, as outlined below.

Item
Director’s Name

Gender

Operational
judgement

Accounting
and
financial
analysis
ability

Operation
management
capability

Crisis
Management

Industry
knowledge

International
market
perspective

Leadership
ability

Decision-making
ability

Risk
management
knowledge
ability

Pan-Chyr Yang

Male

 

Tsu-Der Lee

Male

Che-An Chou

Male

 

Der-Tsai Lee

Male

 

Fei-Peng Li

Male

 

Shu-Hui
Chang

Female

Li-Ching Chen

Female

Shi-Yu Hsiang

Female

Shih-Tsung Chang

Male

Performance Evaluation

According to the company’s “Rules for Performance Evaluation of Board of Directors,” which was approved by Board of Directors on May 17, 2022. The performance evaluation of the Board of Directors and functional committees is conducted annually in accordance with these measures. The Board of Directors’ performance evaluation includes at least five main aspects:

  1. Level of participation in the operation of the company.
  2. Improvement of the quality of decisions by the Board of Directors
  3. Composition and structure of the Board of Directors
  4. Election of directors and continued learning.
  5. Internal control.

To valuate the performance of the functional committees, the evaluation items include at least the following five main aspects:

  1. Level of participation in the operation of the company.
  2. Awareness of the duties of functional committees.
  3. Improvement of the quality of decisions by functional committees.
  4. Composition of functional committees and election of members.
  5. Internal control.

Evaluation result

FY2024

  • The Board of Directors’ performance evaluation for 2024 has been completed, with an overall score of 4.94 out of 5, and the evaluation results were submitted to the Board meeting on February 25, 2025 for reporting.
  • The performance evaluations of the functional committees for 2024, including the Audit Committee, Remuneration Committee, and Sustainable Development and Nominating Committee, have been completed, with scores of 4.99, 4.99, and 4.96 out of 5, respectively. The evaluation results were submitted to the Board meeting on February 25, 2025 for reporting.
  • The self-evaluation results of the Board of Directors, Audit Committee, and Remuneration Committee for 2024 were all rated as “Excellent,” indicating that the overall operations remain sound and effective.
  • In 2024, the Company engaged the Taiwan Corporate Governance Association (TCGA) to conduct an external performance evaluation of the Board of Directors, and the evaluation results were submitted to the Board meeting on February 25, 2025 for reporting.
    Please refer to the following link for more information: 2024 Annual Board Performance External Evaluation PDF

Additionally, the company has disclosed the “Rules for Performance Evaluation of Board of Directors” under the Governance – Major Internal Policies for reference.

Communication between Independent Directors, the internal audit supervisor, and CPAs (e.g., on the Company’s financial and business status, methods, and outcomes).:

  1. The independent directors meet with the internal audit supervisor and the CPAs at least once per quarter through the Audit Committee. Additionally, the independent directors engage in separate discussions with the internal audit supervisor and the CPAs at least once a year.
  2. The auditors report the key findings/results from their audit or review of the company’s financial statements during the Audit Committee meeting and explain the impact of recent regulatory amendments on the Company. All matters are thoroughly discussed and communicated with the attendees.
  3. The internal audit supervisor submits a monthly report to Independent Directors and delivers an internal audit operations report during Audit Committee meetings.

Summary of Communication Between Independent Directors and CPAs (2025)

Date Item Key Points of Communication Outcomes
2025/2/25 Pre-Audit Committee Meeting
  1. The CPAs report the audit results of 2024 financial statements and key audit matters and response to questions from the attendees.
  2. Explain the impact of recent regulatory amendments.
  1. Submitted to the Audit Committee and the Board for approval.
  2. Acknowledged.
2025/5/9 Pre-Audit Committee Meeting
  1. The CPAs report the review result of 2025Q1 financial statements and response to questions from the attendees.
  1. Submitted to the Audit Committee and the Board for approval.
2025/8/8 Pre-Audit Committee Meeting
  1. The CPAs report the review result of 2025Q2 financial statements and response to questions from the attendees.
  2. Explain the impact of recent regulatory amendments.
  1. Submitted to the Audit Committee and the Board for approval.
  2. Acknowledged.
2025/11/10 Pre-Audit Committee Meeting Private Session
  1. The CPAs report the review result of 2025Q3 financial statements and response to questions from the attendees.
  2. Explain the key audit matters.
  1. Submitted to the Audit Committee and the Board for approval.
  2. Acknowledged.

Summary of Communication Between Independent Directors and internal audit supervisor (2025)

Date Item Key Points of Communication Outcomes
2025/2/25 Pre-Audit Committee Meeting
  1. Report on internal audit report and audit follow-up.
  2. Briefing on the amendments to the Company’s various regulations.
  3. 2024 Internal Control System Statement.
  1. Submitted to the Audit Committee and the Board for reporting.
  2. Acknowledged.
  3. Submitted to the Audit Committee and the Board for approval.
2025/5/9 Pre-Audit Committee Meeting
  1. Report on internal audit report and audit follow-up.
  1. Submitted to the Audit Committee and the Board for reporting.
2025/8/8 Pre-Audit Committee Meeting
  1. Report on internal audit report and audit follow-up.
  1. Submitted to the Audit Committee and the Board for reporting.
2025/11/10 Pre-Audit Committee Meeting Private Session
  1. Report on internal audit report and audit follow-up.
  2. Briefing on the 2026 Audit Plan.
  3. Report on the operation of the Whistleblowing System.
  1. Submitted to the Audit Committee and the Board for reporting.
  2. Submitted to the Audit Committee and the Board for approval.
  3. Acknowledged.

Succession Planning for Key Management Positions

The company places great importance on succession planning for key management positions, including President (CEO) and Vice Presidents, in order to ensure long-term business sustainability and organizational resilience. In evaluating successors, in addition to operational management capabilities, professional expertise, and outstanding performance, candidates must also demonstrate alignment with the company’s core values and core competencies—integrity, innovation, professionalism, and a strong results orientation.

There are currently 12 key management personnel at the managerial level and above. Each has a defined job description and career development plan, along with a designated deputy who is trained as a potential successor. The company leverages its existing performance evaluation system to assess the suitability of potential successors, thereby facilitating succession planning and execution. The Human Resources Department is responsible for formulating and implementing the succession plan and reports to the Board of Directors on an annual basis.

Specific Measures and Implementation Practices Include:

  • Effective Communication Mechanism: The top executive regularly convenes strategic planning and execution review meetings with senior executives from various functions to ensure the achievement of company goals.
  • Task-Oriented Projects: Through cross-departmental collaboration, the company has organized six sessions of the “Asia Pacific Biotech Investment Forum” since 2014, featuring 32 keynote speeches, 8 panel discussions, 38 companies presenting R&D progress, and nearly 60 successful matchmaking meetings.
  • Diverse Learning Organization: A monthly expert sharing meeting, personally hosted by the top executive, where department heads share their expertise or recent project experiences, fostering mutual learning through professional presentations and discussions. These sessions primarily focus on “innovation” and “replicating and learning from successful experiences”.
  • External Consultant Guidance: The company also holds the “Diamond Lecture” on an ad hoc basis, where professional consultants provide in-depth guidance to employees on specialized knowledge.
  • Regular Talent Pool Review: The company conducts an annual review of managers and potential successors to maintain a sufficient talent pool for succession.
  • Succession Plan Effectiveness Tracking: The company reviews the overall implementation of the succession plan on an annual basis and makes flexible adjustments as needed.